Loading…
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company also offers include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $925M | $213M | $29M | $107M | 1.5% | 7.5% | -179.8% |
| 2024 | $861M | $174M | $-36M | $50M | -2.4% | 7.5% | -62.7% |
| 2023 | $801M | $119M | $-97M | $58M | -6.5% | 11.6% | -65.0% |
| 2022 | $718M | $-90M | $-277M | $5M | -19.8% | - | - |
| 2021 | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total Revenue | - | 717.80 | 800.90 | 860.80 | 925.40 |
| Operating Revenue | - | 717.80 | 800.90 | 860.80 | 925.40 |
| Cost Of Revenue | - | 407.70 | 444.50 | 461.10 | 486.80 |
| Gross Profit | - | 310.10 | 356.40 | 399.70 | 438.60 |
| Operating Expense | - | 392.60 | 371.80 | 376.10 | 387.10 |
| Research And Development | - | 30.30 | 31.70 | 35 | 38.90 |
| Selling General And Administration | - | 362.30 | 340.10 | 341.10 | 348.20 |
| Total Expenses | - | 800.30 | 816.30 | 837.20 | 873.90 |
| Operating Income | - | -82.50 | -15.40 | 23.60 | 51.50 |
| Total Operating Income As Reported | - | -297.80 | -21.90 | 24.80 | 51.50 |
| EBITDA | - | -89.60 | 119.40 | 174.40 | 212.90 |
| Normalized EBITDA | - | 93 | 153 | 180.70 | 201.30 |
| EBIT | - | -264.10 | -43.40 | 24 | 74.90 |
| Interest Income | - | 0.60 | 4.80 | 6.60 | 12.10 |
| Interest Expense | - | 42.50 | 61.90 | 57.90 | 42.20 |
| Net Interest Income | - | -41.90 | -57.10 | -51.30 | -30.10 |
| Other Non Operating Income Expenses | - | 0.40 | 0.80 | 0.10 | -0.30 |
| Other Income Expense | - | -182.20 | -32.80 | -6.20 | 11.30 |
| Interest Income Non Operating | - | 0.60 | 4.80 | 6.60 | 12.10 |
| Interest Expense Non Operating | - | 42.50 | 61.90 | 57.90 | 42.20 |
| Net Non Operating Interest Income Expense | - | -41.90 | -57.10 | -51.30 | -30.10 |
| Pretax Income | - | -306.60 | -105.30 | -33.90 | 32.70 |
| Tax Provision | - | -18.20 | -6.60 | 2.70 | 2.90 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | -10.77 | -2.12 | -1.32 | 1.03 |
| Net Income Continuous Operations | - | -288.40 | -98.70 | -36.60 | 29.80 |
| Net Income From Continuing And Discontinued Operation | - | -276.90 | -96.90 | -36.10 | 28.80 |
| Net Income From Continuing Operation Net Minority Interest | - | -276.90 | -96.90 | -36.10 | 28.80 |
| Net Income | - | -276.90 | -96.90 | -36.10 | 28.80 |
| Net Income Common Stockholders | - | -276.90 | -96.90 | -36.10 | 28.80 |
| Net Income Including Noncontrolling Interests | - | -288.40 | -98.70 | -36.60 | 29.80 |
| Normalized Income | - | -105.07 | -65.42 | -31.12 | 18.23 |
| Diluted NI Availto Com Stockholders | - | -276.90 | -96.90 | -36.10 | 28.80 |
| Basic Average Shares | - | 181.15 | 196.37 | 204.99 | 261.15 |
| Diluted Average Shares | - | 181.15 | 196.37 | 204.99 | 261.15 |
| Reconciled Depreciation | - | 174.50 | 162.80 | 150.40 | 138 |
| Reconciled Cost Of Revenue | - | 407.70 | 444.50 | 461.10 | 486.80 |
| Total Unusual Items | - | -182.60 | -33.60 | -6.30 | 11.60 |
| Total Unusual Items Excluding Goodwill | - | -182.60 | -33.60 | -6.30 | 11.60 |
| Minority Interests | - | 11.50 | 1.80 | 0.50 | -1 |
| Special Income Charges | - | -215.30 | -9.10 | 1.20 | -5.80 |
| Gain On Sale Of Business | - | 0 | -6.50 | 1.20 | 0 |
| Other Special Charges | - | - | 2.60 | - | 5.80 |
| Write Off | - | 3.50 | 0 | 0 | - |
| Impairment Of Capital Assets | - | 211.80 | 0 | 0 | - |
| Gain On Sale Of Security | - | 32.70 | -24.50 | -7.50 | 17.40 |
Industrials sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| Mirion Technologies, Inc.this co. | MIR | $4.5B | 154.78↑ premium | 2.39 | 1.5% | 24.76 |
| WillScot Holdings Corporation | WSC | $4.8B | -90.45 | 5.60 | -6.2% | 14.32 |
| AAR Corp. | AIR | $4.6B | 367.52 | 3.79 | 1.0% | 32.71 |
| Resideo Technologies, Inc. | REZI | $4.6B | - | 1.57 | -19.3% | - |
| RXO, Inc. | RXO | $4.6B | -45.57 |
| - |
| - |
| - |
| - |
| - |
| - |
| 2.96 |
| -6.5% |
| 144.72 |
| CSW Industrials, Inc. | CSW | $4.4B | 39.29 | 4.19 | 10.7% | 22.62 |
| Franklin Electric Co., Inc. | FELE | $4.3B | 29.58 | 3.28 | 11.1% | 16.66 |
| Brady Corporation | BRC | $4.2B | 22.18 | 3.52 | 15.9% | 14.80 |
| AZZ Inc. | AZZ | $4.2B | 13.10 | 3.11 | 23.7% | 8.29 |
| Peer Median | - | 22.18 | 3.40 | 5.8% | 16.66 | |